Merck & Co. Inc.

NYSE: MRK · Real-Time Price · USD
84.19
1.43 (1.73%)
At close: Aug 15, 2025, 9:57 AM

Merck & Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
13.24B 6.84B 12.69B 8.1B
Short-Term Investments
447M 252M 498M n/a
Long-Term Investments
463M 252M 1.01B 370M
Other Long-Term Assets
16.04B 12B 9.53B 11.58B
Receivables
10.28B 10.35B 9.45B 9.23B
Inventory
6.11B 6.36B 5.91B 5.95B
Other Current Assets
8.71B 8.37B 7.17B 6.99B
Total Current Assets
38.78B 32.17B 35.72B 30.27B
Property-Plant & Equipment
23.78B 23.05B 21.42B 19.28B
Goodwill & Intangibles
38.04B 39.21B 41.47B 44.2B
Total Long-Term Assets
78.32B 74.51B 73.44B 75.43B
Total Assets
117.11B 106.67B 109.16B 105.69B
Account Payables
4.08B 3.92B 4.26B 4.61B
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
2.65B 1.37B 1.95B 2.41B
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
28.42B 25.69B 24.24B 23.87B
Long-Term Debt
34.46B 33.68B 28.75B 30.69B
Other Long-Term Liabilities
6.46B 8.79B 8.32B 9.43B
Total Long-Term Liabilities
42.31B 43.35B 38.86B 43.56B
Total Liabilities
70.73B 69.04B 63.1B 67.44B
Total Debt
37.11B 35.05B 30.69B 33.1B
Common Stock
1.79B 1.79B 1.79B 1.79B
Retained Earnings
63.07B 53.9B 61.08B 53.7B
Comprehensive Income
-4.95B -5.16B -4.77B -4.43B
Shareholders Equity
46.31B 37.58B 45.99B 38.18B
Total Investments
910M 504M 1.51B 370M